Last update 25 May 2025

Cellgram-DC

Overview

Basic Info

Drug Type
Immune cell therapy
Synonyms-
Target-
Action
stimulants
Mechanism
Immunostimulants
Therapeutic Areas
NeoplasmsDigestive System DisordersEndocrinology and Metabolic Disease+ [1]
Active Indication-
Inactive Indication
Liver Cirrhosis, AlcoholicMetastatic castration-resistant prostate cancerPancreatic Cancer+ [1]
Originator Organization
Pharmicell Co., Ltd.Pharmicell Co., Ltd.
Active Organization-
Inactive Organization
Pharmicell Co., Ltd.Pharmicell Co., Ltd.
License Organization-
Drug Highest PhaseDiscontinuedPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with Cellgram-DC
NCT04615845
/ TerminatedPhase 1
An Open Label, Single-center, Phase 1 Study to Evaluate the Safety of Cancer Immunotherapy With Autologous Dendritic Cells in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
NCT04614051
/ TerminatedPhase 1
An Open Label, Single-center, Phase 1 Study to Evaluate the Safety of Cancer Immunotherapy With Autologous Dendritic Cells in Patients With Advanced or Recurrent Epithelial Ovarian Cancer
NCT03838250
/ Unknown statusPhase 1
A Phase I, Open-Label, Single-Dose Study to Evaluate the Safety and Efficacy of Hepatic Artery Injection of Autologous Human Bone Marrow-Derived Mesenchymal Stem Cells (Cellgram™) in Patients With Alcoholic Liver Cirrhosis
100 Clinical Results associated with Cellgram-DC
Login to view more data
100 Translational Medicine associated with Cellgram-DC
Login to view more data
100 Patents (Medical) associated with Cellgram-DC
Login to view more data
100 Deals associated with Cellgram-DC
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Metastatic castration-resistant prostate cancerPhase 1
United States
Pharmicell Co., Ltd.Pharmicell Co., Ltd.
21 Jun 2021
Recurrent ovarian cancerPhase 1
United States
Pharmicell Co., Ltd.Pharmicell Co., Ltd.
30 Mar 2021
Pancreatic CancerPhase 1
South Korea
Pharmicell Co., Ltd.Pharmicell Co., Ltd.
08 Nov 2020
Liver Cirrhosis, AlcoholicPhase 1
United States
Pharmicell Co., Ltd.Pharmicell Co., Ltd.
20 Jun 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free